August 31, 2026 · Health care / Prescription drugs / Most-favored-nation pricing
Trump announces nine additional pharmaceutical most-favored-nation pricing agreements
The White House announced agreements with nine additional pharmaceutical manufacturers on August 31, bringing the administration-reported total to 26 companies. Reuters independently reported the agreements and said participating manufacturers receive tariff relief while extending most-favored-nation pricing commitments. The existence of the agreements is documented; administration estimates of future Medicaid and broader-market savings remain projections rather than realized outcomes.
Open the full dated evidence record →